Lansoprazole
لانسوپرازول
🍽️ Alimentary Tract And MetabolismProton-pump inhibitor
Market / country: 🇺🇸 USA
Prevacid (US)
🧮 Dose calculator
Peptic ulcer disease · Regimen source: FDA Lansoprazole · 2.1
- • Maintenance after healing: 15 mg daily. FDA Lansoprazole · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to any component; with rilpivirine-containing products. FDA Lansoprazole · 4
- ⛔ Not effective under 1 year of age. FDA Lansoprazole · 8.4
Formulations
- 15 mg capsule — capsule 🇺🇸 USA FDA Lansoprazole · 3
- 30 mg capsule — capsule 🇺🇸 USA FDA Lansoprazole · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Lansoprazole · 8.1
“Risk Summary Available data from published observational studies overall do not indicate an association of adverse pregnancy outcomes with lansoprazole treatment (see Data) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Lansoprazole · 8.2
“Risk Summary There is no information regarding the presence of lansoprazole in human milk, the effects on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Lansoprazole · 8.4
“The safety and effectiveness of lansoprazole have been established in pediatric patients one year to 17 years of age for short-term treatment of symptomatic GERD and erosive esophagitis.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Lansoprazole · 8.5
“Of the total number of patients (n=21,486) in clinical studies of lansoprazole, 16% of patients were aged 65 years and over, while 4% were 75 years and over.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA077255
- DailyMed (FDA label)FDA Lansoprazole
- MedlinePlus (NIH)LansoprazoleLansoprazole, Clarithromycin, and Amoxicillin
- WHO ATC/DDDA02BC03
- Darooyab (Iran)Lansoprazole
🇮🇷 Registered in Iran Darooyab · G-2600/Lansoprazole
Dosage forms with Iranian generic codes, per Darooyab.
- 12904 · LANSOPRAZOLE 15MG TAB · قرص لانسوپرازول ۱۵ میلیگرم
- 06770 · LANSOPRAZOLE 15MG CAP · کپسول لانسوپرازول ۱۵ میلیگرم
- 06222 · LANSOPRAZOLE 30MG CAP · کپسول لانسوپرازول ۳۰ میلیگرم
- 12720 · LANSOPRAZOLE 30MG TAB · قرص لانسوپرازول ۳۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Lansoprazole · 3FDA Lansoprazole · 2.1FDA Lansoprazole · 2.3FDA Lansoprazole · 2.2FDA Lansoprazole · 4FDA Lansoprazole · 8.4FDA Lansoprazole · 8.1FDA Lansoprazole · 8.2FDA Lansoprazole · 8.5FDA Lansoprazole · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2600/Lansoprazole
- Clinical review⚠ Unverified